SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 19.89 |
| Enterprise Value ($M) | 16.15 |
| Book Value ($M) | 28.56 |
| Book Value / Share | 1.33 |
| Price / Book | 0.70 |
| NCAV ($M) | 25.23 |
| NCAV / Share | 1.18 |
| Price / NCAV | 0.79 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.76 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.57 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.06 |
| Current Ratio | 10.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 28.57 |
| Assets | 31.90 |
| Liabilities | 3.34 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 68,643 | 310,805 | 22.09 | |
| 60,952 | 216,777 | 28.12 | |
| 96,093 | 410,520 | 23.41 | |
| 91,166 | 317,526 | 28.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ELDN – Eledon Pharmaceuticals, Inc. | ELTX – Elicio Therapeutics, Inc. |
| ELUT – Elutia Inc. | ENSC – Ensysce Biosciences, Inc. |
| ENTO – Entero Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io